CD4 and cancer: Another alteration in the TME induced by TGF-β activation is changes in several stromal cells, including cancer-associated fibroblasts, natural killer cells, tumor-associated neutrophils, tumor-associated macrophages, naïve CD4+ T cells, type 1 T helper cells, and regulatory T lymphocytes [6].